Related Experiment Video
Updated: Feb 24, 2026

De Novo Generation of Somatic Stem Cells by YAP/TAZ
Published on: May 7, 2018
New Kid on the Block
1Institute of Molecular Medicine and Cell Research, Faculty of Medicine, Albert-Ludwigs-University Freiburg, and German Cancer Consortium (DKTK), Partner site Freiburg, Freiburg, Germany.
Insights
Selective targeting of cysteine cathepsins, like cathepsin B, remains difficult. A novel designed ankyrin repeat protein (DARPin) offers a promising new method for precisely inhibiting specific proteases.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Cysteine cathepsins are crucial proteases implicated in numerous physiological and pathological functions.
- Developing selective inhibitors for individual cathepsins is a significant challenge in biochemical research.
Discussion:
- This editorial examines a recent study that utilized a designed ankyrin repeat protein (DARPin) for targeted inhibition.
- The focus is on the application of DARPins as a novel strategy for selective cathepsin B targeting.
Key Insights:
- Designed ankyrin repeat proteins (DARPins) present a new molecular tool for protease research.
- This approach demonstrates potential for overcoming the limitations of current methods in cathepsin B inhibition.
Outlook:
- Further exploration of DARPins could lead to advanced diagnostic and therapeutic agents.
- This strategy may be applicable to targeting other proteases beyond cathepsin B.
Abstract:
Cysteine cathepsins are a group of proteases involved in many physiological and pathological processes. Yet, the selective detection and inhibition of individual cathepsins is still challenging. This editorial is discussing the context of a recent work introducing a designed ankyrin repeat protein (DARPin) as novel approach for selective targeting of the protease cathepsin B.
Related Concept Videos
First Impression
Transition Zone
Bullying
Neuromuscular Junction And Blockade
Impulse
Additionally, it can be shown that the...
Depolarizing Blockers: Pharmocokinetics

